AML (Acute Myelogenous Leukemia) Clinical Trials in Tianjin
2 recruitingTianjin, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
AMLMDSLeukemia+2 more
Cullgen (Shanghai),Inc45 enrolled3 locationsNCT07347171
Recruiting
Phase 2
Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT
AML (Acute Myelogenous Leukemia)
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06783790